Center for Substance Abuse Prevention; Notice of Meeting, 1378 [2018-00369]
Download as PDF
<![CDATA[
srobinson on DSK9F5VC42PROD with NOTICES
1378
Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award (OIA) II.
Date: March 8–9, 2018.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Caron A. Lyman, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W126,
Bethesda, MD 20892–9750, 240–276–6348,
lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–9—
Drug Development.
Date: March 9, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Bethesda, MD 20892–
9750, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–1:
Development of Software Tools for Post
Radiation Therapy Surveillance.
Date: March 13–14, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Bethesda, MD 20892–
9750, 240–276–6349, ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Emerging
Questions in Cancer Systems Biology (U01).
Date: March 16, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
2E908, Rockville, MD 20850.
Contact Person: Timothy C. Meeker, MD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W606, Bethesda, MD 20892–9750,
240–276–6464, meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
VerDate Sep<11>2014
00:05 Jan 11, 2018
Jkt 244001
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 5, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–00297 Filed 1–10–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given for the meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
National Advisory Council (CSAP NAC)
on February 14, 2018.
The Council was established to advise
the Secretary, Department of Health and
Human Services (HHS); the Assistant
Secretary for Mental Health and
Substance Use, SAMHSA; and Director,
CSAP concerning matters relating to the
activities carried out by and through the
Center and the policies respecting such
activities.
The meeting will be open to the
public and will include the discussion
of the substance use prevention
workforce and opioid use prevention.
The meeting will also include updates
on CSAP program developments.
The meeting will be held in Rockville,
Maryland. Attendance by the public
will be limited to the space available.
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
Council. Written submissions should be
forwarded to the contact person on or
before one week prior to the meeting.
Oral presentations from the public will
be scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations should notify
the contact on or before one week prior
to the meeting. Five minutes maximum
will be allotted for each presentation.
To attend onsite, submit written or
brief oral comments, or request special
accommodations for persons with
disabilities, please register at the
SAMHSA Committees’ website, https://
nac.samhsa.gov/Registration/
meetingsRegistration.aspx, or
communicate with the CSAP Council’s
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Designated Federal Officer (see contact
information below).
Substantive program information may
be obtained after the meeting by
accessing the SAMHSA Committee
website, https://nac.samhsa.gov/, or by
contacting the Designated Federal
Officer.
Committee Name: Substance Abuse and
Mental Health Services Administration,
Center for Substance Abuse Prevention
National Advisory Council.
Date/Time/Type: February 14, 2018, from
9:30 a.m. to 4:30 p.m. EST: (OPEN).
Place: SAMHSA, 5600 Fishers Lane, Room
5A02, Rockville, MD 20852, Adobe Connect
webcast: https://samhsacsap.adobeconnect.com/nac/.
Contact: Matthew J. Aumen, Designated
Federal Officer, SAMHSA CSAP NAC, 5600
Fishers Lane, Rockville, MD 20852,
Telephone: 240–276–2440, Fax: 301–480–
8480, Email: matthew.aumen@
samhsa.hhs.gov.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2018–00369 Filed 1–10–18; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[Docket No. FWS–HQ–IA–2017–0086;
FXIA16710900000–178–FF09A30000]
Foreign Endangered and Threatened
Species; Receipt of Permit
Applications
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of permit
applications.
AGENCY:
We, the U.S. Fish and
Wildlife Service, invite the public to
comment on applications to conduct
certain activities with foreign
endangered and threatened species.
With some exceptions, the Endangered
Species Act prohibits activities with
listed species unless Federal
authorization is acquired that allows
such activities. The ESA also requires
that we invite public comment before
issuing these permits.
DATES: We must receive comments by
February 12, 2018.
ADDRESSES:
Document availability: The
applications, as well as any comments
and other materials that we receive, will
be available for public inspection online
in Docket No. FWS–HQ–IA–2017–0086
at https://www.regulations.gov.
Submitting comments: You may
submit comments by one of the
following methods:
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 83, Number 8 (Thursday, January 11, 2018)]
[Notices]
[Page 1378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00369]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given for the
meeting of the Substance Abuse and Mental Health Services
Administration's (SAMHSA) Center for Substance Abuse Prevention
National Advisory Council (CSAP NAC) on February 14, 2018.
The Council was established to advise the Secretary, Department of
Health and Human Services (HHS); the Assistant Secretary for Mental
Health and Substance Use, SAMHSA; and Director, CSAP concerning matters
relating to the activities carried out by and through the Center and
the policies respecting such activities.
The meeting will be open to the public and will include the
discussion of the substance use prevention workforce and opioid use
prevention. The meeting will also include updates on CSAP program
developments.
The meeting will be held in Rockville, Maryland. Attendance by the
public will be limited to the space available. Interested persons may
present data, information, or views, orally or in writing, on issues
pending before the Council. Written submissions should be forwarded to
the contact person on or before one week prior to the meeting. Oral
presentations from the public will be scheduled at the conclusion of
the meeting. Individuals interested in making oral presentations should
notify the contact on or before one week prior to the meeting. Five
minutes maximum will be allotted for each presentation.
To attend onsite, submit written or brief oral comments, or request
special accommodations for persons with disabilities, please register
at the SAMHSA Committees' website, https://nac.samhsa.gov/Registration/meetingsRegistration.aspx, or communicate with the CSAP Council's
Designated Federal Officer (see contact information below).
Substantive program information may be obtained after the meeting
by accessing the SAMHSA Committee website, https://nac.samhsa.gov/, or
by contacting the Designated Federal Officer.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention National
Advisory Council.
Date/Time/Type: February 14, 2018, from 9:30 a.m. to 4:30 p.m.
EST: (OPEN).
Place: SAMHSA, 5600 Fishers Lane, Room 5A02, Rockville, MD
20852, Adobe Connect webcast: https://samhsa-csap.adobeconnect.com/nac/.
Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA
CSAP NAC, 5600 Fishers Lane, Rockville, MD 20852, Telephone: 240-
276-2440, Fax: 301-480-8480, Email: [email protected].
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2018-00369 Filed 1-10-18; 8:45 am]
BILLING CODE 4162-20-P
